Significance of Adrenocorticotropin Stimulation Test in the Diagnosis of an Aldosterone-Producing Adenoma

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 9, 2011, Pages 2771-2778

  Sonoyama, Takuhiro ^a   Sone, Masakatsu ^a   Miyashita, Kazutoshi ^a   Tamura, Naohisa ^a   Yamahara, Kenichi ^a   Park, Kwijun ^a   Oyamada, Naofumi ^a   Taura, Daisuke ^a   Inuzuka, Megumi ^a   Kojima, Katsutoshi ^a   Honda, Kyoko ^a   Fukunaga, Yasutomo ^a   Kanamoto, Naotetsu ^a   Miura, Masako ^a   Yasoda, Akihiro ^a   Arai, Hiroshi ^a   Itoh, Hiroshi ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE;

ACTH SECRETING ADENOMA; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN TEST; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HORMONE SENSITIVITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICOTROPIC HORMONE; ALDOSTERONE; DEXAMETHASONE; FEMALE; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED;

EID: 80052516560     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-0573     Document Type: Article

References (40)

1. Rossi G.P., Bernini G., Caliumi C., Desideri G., Fabris B., Ferri C., Ganzaroli C., Giacchetti G., Letizia C., Maccario M., Mallamaci F., Mannelli M., Mattarello M.J., Moretti A., Palumbo G., Parenti G., Porteri E., Semplicini A., Rizzoni D., Rossi E., Boscaro M., Pessina A.C., Mantero F.; PAPY Study Investigators 2006 A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. JAm Coll Cardiol 48:2293-2300 (Pubitemid 44873058)
2. Fardella C.E., Mosso L., Gómez-Sánchez C., Cortés P., Soto J., Gómez L., Pinto M., Huete A., Oestreicher E., Foradori A., Montero J. 2000 Primary aldosteronism in essential hypertensives: Prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 85:1863-1867 (Pubitemid 32269290)
3. Mulatero P., Dluhy R.G., Giacchetti G., Boscaro M., Veglio F., Stewart P.M. 2005 Diagnosis of primary aldosteronism: From screening to subtype differentiation. Trends Endocrinol Metab 16:114-119 (Pubitemid 40432461)
4. Loh K.C., Koay E.S., Khaw M.C., Emmanuel S.C., Young Jr W.F. 2000 Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 85:2854-2859 (Pubitemid 32269163)
5. Fogari R., Preti P., Zoppi A., Rinaldi A., Fogari E., Mugellini A. 2007 Prevalence of primary aldosteronism among unselected hypertensive patients: A prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. Hypertens Res 30:111-117 (Pubitemid 46541784)
6. Omura M., Saito J., Yamaguchi K., Kakuta Y., Nishikawa T. 2004 Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27:193-202 (Pubitemid 38489081)
7. Milliez P., Girerd X., Plouin P.F., Blacher J., Safar M.E., Mourad J.J. 2005 Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243-1248 (Pubitemid 40523144)
8. Catena C., Colussi G., Lapenna R., Nadalini E., Chiuch A., Gianfagna P., Sechi L.A. 2007 Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 50:911-918 (Pubitemid 350287534)
9. Sechi L.A., Novello M., Lapenna R., Baroselli S., Nadalini E., Colussi G.L., Catena C. 2006 Long-term renal outcomes in patients with primary aldosteronism. JAMA 295:2638-2645 (Pubitemid 43882339)
10. Rossi G.P., Bernini G., Desideri G., Fabris B., Ferri C., Giacchetti G., Letizia C., Maccario M., Mannelli M., Matterello M.J., Montemurro D., Palumbo G., Rizzoni D., Rossi E., Pessina A.C., Mantero F.; PAPY Study Participants. 2006 Renal damage in primary aldosteronism: Results of the PAPY Study. Hypertension 48:232-238 (Pubitemid 44309817)
11. Funder J.W., Carey R.M., Fardella C., Gomez-Sanchez C.E., Mantero F., Stowasser M., Young Jr W.F., Montori V.M. 2008 Case detection, diagnosis, and treatment of patients with primary aldosteronism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:3266-3281
12. Ogihara T., Kikuchi K., Matsuoka H., Fujita T., Higaki J., Horiuchi M., Imai Y., Imaizumi T., Ito S., Iwao H., Kario K., Kawano Y, Kim- Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H; Japanese Society of Hypertension Committee 2009 The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 32:3-107
13. Lyons D.F., Kem D.C., Brown R.D., Hanson C.S., Carollo M.L. 1983 Single dose captopril as a diagnostic test for primary aldosteronism. J Clin Endocrinol Metab 57:892-896 (Pubitemid 14204282)
14. Holland O.B., Brown H., Kuhnert L., Fairchild C., Risk M., Gomez-Sanchez C.E. 1984 Further evaluation of saline infusion for the diagnosis of primary aldosteronism. Hypertension 6:717-723 (Pubitemid 15210514)
15. Agharazii M., Douville P., Grose J.H., Lebel M. 2001 Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension 37:1440-1443 (Pubitemid 34225389)
16. Streeten D.H., Tomycz N., Anderson G.H. 1979 Reliability of screening methods for the diagnosis of primary aldosteronism. Am J Med 67:403-413 (Pubitemid 10237023)
17. YoungW.F.2007 Primary aldosteronism: Renaissance of a syndrome. Clin Endocrinol (Oxf) 66:607-618 (Pubitemid 46699525)
18. Magill S.B., Raff H., Shaker J.L., Brickner R.C., Knechtges T.E., Kehoe M.E., Findling J.W. 2001 Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 86:1066-1071 (Pubitemid 32322983)
19. Young W.F., Stanson A.W., Thompson G.B., Grant C.S., Farley D.R., Van Heerden J.A. 2004 Role for adrenal venous sampling in primary aldosteronism. Surgery 136:1227-1235 (Pubitemid 39647538)
20. Young W.F., Stanson A.W. 2009 What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? Clin Endocrinol (Oxf) 70:14-17
21. Nomura K., Kusakabe K., Maki M., Ito Y., Aiba M., Demura H. 1990 Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppression scintigraphy: Relationship to adenoma size and functional activity. J Clin Endocrinol Metab 71:825-830
22. Mansoor G.A., Malchoff C.D., Arici M.H., Karimeddini M.K., Whalen G.F. 2002 Unilateral adrenal hyperplasia causing primary aldosteronism: Limitations of I-131 norcholesterol scanning. Am J Hypertens 15:459-464 (Pubitemid 34478486)
23. Schambelan M., Brust N.L., Chang B.C., Slater K.L., Biglieri E.G. 1976 Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism. J Clin Endocrinol Metab 43: 115-131
24. Biglieri E.G. 1991 Spectrum of mineralocorticoid hypertension. Hypertension 17:251-261
25. Wisgerhof M., Carpenter P.C., Brown R.D. 1978 Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism. J Clin Endocrinol Metab 47:938-943 (Pubitemid 9047376)
26. Wisgerhof M., Brown R.D., Hogan M.J., Carpenter P.C., Edis A.J. 1981 The plasma aldosterone response to angiotensin II infusion in aldosterone- producing adenoma and idiopathic hyperaldosteronism. J Clin Endocrinol Metab 52:195-198 (Pubitemid 11183610)
27. Tunny T.J., Klemm S.A., StowasserM., Gordon R.D. 1993 Angiotensinresponsive aldosterone-producing adenomas: Postoperative disappearance of aldosterone response to angiotensin. Clin Exp Pharmacol Physiol 20:306-309 (Pubitemid 23140202)
28. Stowasser M., Klemm S.A., Tunny T.J., Gordon R.D. 1995 Plasma aldosterone response to ACTH in subtypes of primary aldosteronism. Clin Exp Pharmacol Physiol 22:460-462
29. Stowasser M., Bachmann A.W., Tunny T.J., Gordon R.D. 1996 Production of 18-oxo-cortisol in subtypes of primary aldosteronism. Clin Exp Pharmacol Physiol 23:591-593 (Pubitemid 26186450)
30. Phillips J.L., Walther M.M., Pezzullo J.C., Rayford W., Choyke P.L., Berman A.A., Linehan W.M., Doppman J.L., Gill Jr J.R. 2000 Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 85:4526-4533 (Pubitemid 32157628)
31. Sheaves R., Goldin J., Reznek R.H., Chew S.L., Dacie J.E., Lowe D.G., Ross R.J., Wass J.A., Besser G.M., Grossman A.B. 1996 Relative value of computed tomography scanning and venous sampling in establishing the cause of primary hyperaldosteronism. Eur J Endocrinol 134: 308-313 (Pubitemid 26108149)
32. Biglieri E.G., Irony I., Kater C.E. 1989 Identification and implications of new types of mineralocorticoid hypertension. J Steroid Biochem 32:199-204 (Pubitemid 19031481)
33. Yamahara K., Itoh H., Yamamoto A., Sasano H., Masatsugu K., Sawada N., Fukunaga Y., Sakaguchi S., Sone M., Yurugi T., Nakao K. 2002 New diagnostic procedure for primary aldosteronism: Adrenal venous sampling under adrenocorticotropic hormone and angiotensin II receptor blocker-application to a case of bilateral multiple adrenal microadenomas. Hypertens Res 25:145-152 (Pubitemid 34464441)
34. Kem D.C., Weinberger M.H., Higgins J.R., Kramer N.J., Gomez-Sanchez C., Holland O.B. 1978 Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension. J Clin Endocrinol Metab 46:552-560
35. Reincke M., Beuschlein F., Latronico A.C., Arlt W., Chrousos G.P., Allolio B. 1997 Expression of adrenocorticotrophic hormone receptor mRNA in human adrenocortical neoplasms: Correlation with P450scc expression. Clin Endocrinol (Oxf) 46:619-626 (Pubitemid 27286935)
36. Mulatero P., Bertello C., Sukor N., Gordon R., Rossato D., Daunt N., Leggett D., Mengozzi G., Veglio F., Stowasser M. 2010 Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism. Hypertension 55:667-673
37. Seccia T.M., Miotto D., De Toni R., Pitter G., Mantero F., Pessina A.C., Rossi G.P. 2009 Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: Comparison of 3 different protocols. Hypertension 53:761-766
38. Solar M., Ceral J., Krajina A., Ballon M., Malirova E., Brodak M., Cap J. 2010 Adrenal venous sampling: Where is the aldosterone disappearing to? Cardiovasc Intervent Radiol 33:760-765
39. Ceral J., Solar M., Krajina A., Ballon M., Suba P., Cap J. 2010 Adrenal venous sampling in primary aldosteronism: A low dilution of adrenal venous blood is crucial for a correct interpretation of the results. Eur J Endocrinol 162:101-107
40. Rossi G.P., Belfiore A., Bernini G., Desideri G., Fabris B., Ferri C., Giacchetti G., Letizia C., Maccario M., Mallamaci F., Mannelli M., Palumbo G., Rizzoni D., Rossi E., Agabiti-Rosei E., Pessina A.C., Mantero F; Primary Aldosteronism Prevalence in Italy Study Investigators 2007 Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 50: 424-431 (Pubitemid 47205795)